The protective effect of methylprednisolone against cisplatin-induced nephrotoxicity in patients with urothelial tumors

International Journal of Urology

Volumn 3, Issue 5, 1996, Pages 343-347

  Uozumi, Jiro ^a   Koikawa, Yasuhiro ^a   Yasumasu, Tetsuo ^a   Tokuda, Noriaki ^a   Kumazawa, Joichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cisplatin; Human; Methylprednisolone; Nephrotoxicity

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CREATININE; DOXORUBICIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOCORTICOID; METHOTREXATE; METHYLPREDNISOLONE; N ACETYL BETA GLUCOSAMINIDASE; VINBLASTINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFICACY; FEMALE; HUMAN; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; URINE LEVEL; UROGENITAL TRACT TUMOR;

EID: 0029784986     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1996.tb00551.x     Document Type: Article

References (17)

1. Uozumi J, Sagiyama K, Aoki K, Iwamoto Y, Baba T. Effectiveness of "two-route chemotherapy" using cisplatin and its antidote, sodium thiosulfate, on lifespan of rats bearing metastatic liver tumors. Cancer Treat Rep 1983;67:1067-1074.
2. Howell SB, Pfeifle CE, Wung WE, Olshen RA. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate. Cancer Res 1983;43:1426-1431.
3. Borch RF, Pleasants ME. Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model. Proc Natl Acad Sci USA 1979;76:6611-6614.
4. Ross DA, Gale GR. Reduction of the renal toxicity of cis-dichlorodiamineplatinum (II) by probenecid. Cancer Treat Rep 1979;63:781-787.
5. Yuhas JM, Culo F. Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum (II) by WR-2721 without altering its antitumor properties. Cancer Treat Rep 1980;64:75-64.
6. McGiness JE, Proctor PH, Demopoulos HB, Hokanson JA, Kirkpatrick DS. Amelioration of cisplatinum nephrotoxicity by orgotein (superoxide dismutase). Physiol Chem Physics 1978; 10:267-277.
7. Hayes DM, Cvitkovic E, Golbey RB, Scheiner E, Helson L, Krakoff IH. High dose cis-platinum diamminedichloride. Amelioration of renal toxicity by mannitol diuresis. Cancer 1977;39:1372-1381.
8. Earhart RH, Martin PA,Tutsch KD, Ertürk E, Wheeler RH, Bull FE. Improvement in the therapeutic index of cisplatin (NSC 119875) by pharmacologically induced chloruresis in the rat. Cancer Res 1983;43:1187-1194.
9. Uozumi J, Koikawa Y, Ueda T. Methylprednisolone reduces the nephrotoxicity caused by cisplatin. J Pharmacobio-Dyn 1992;15:693-697.
10. Koikawa Y, Uozumi J, Ueda T, Yasumasu T, Kumazawa J. Prophylactic effect of methylprednisolone against cisplatin-induced nephrotoxicity in rats. Toxicol Lett 1993;66:281-285.
11. Uozumi J, Koikawa Y, Yasumasu Y, Ueda T, Kumazawa J. The effect of methylprednisolone on cisplatin-induced nephrotoxicity in rat renal cortical slices. Res Exp Med 1995;195:231-235.
12. Rich WM, Abdulhayoglu G, DiSaia PJ. Methyl-prednisolone as an antiemetic during cancer chemotherapy-a pilot study. Gynecol Oncol 1980; 9:193-198.
13. Umeki S, Watanabe M, Yagi S, Soejima R. Supplemental fosfomycin and/or steroids that reduce cisplatin-induced nephrotoxicity. Am J Med Sci 1988;295: 6-10.
14. Litterest CL, Smith JH, Smith MA, Uozumi J, Copley M. Sensitivity of urinary enzymes as indications of renal toxicity of the anticancer drug cis-platin. Uremia Invest 1985-1986;9:111-117.
15. Groth S, Nielsen H, Sorensen JB, Christensen AB, Pedersen AG, Rorth M. Acute and long-term nephrotoxicity of cis-platinum in man. Cancer Chemother Pharmacol 1986;17:191-196.
16. Meijer S, Mulder NH, Sleijfer DT, deJong PE, Sluiter WJ, Schraffordt Koops H, van der Hem GK. Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of testicular carcinoma. Cancer Chemother Pharmacol 1982;18:27-30.
17. Koikawa Y. Prophylactic effectr of methylprednisolone on cisplatin-induced nephrotoxicity. Fukuoka Acta Med 1995;86:31-39.